
Jun 16, 2024, 04:13
Most viewed in the last 7 days from JAMA Oncology
Akash Maniam, Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared a post by JAMA Oncology on LinkedIn:
“Excellent analysis in an increasingly relevant and important field.”
Quoting JAMA Oncology’s post:
“Most viewed in the last 7 days from JAMA Oncology: Are androgen receptor signaling inhibitors associated with increased risk of CV events in men with advanced and metastatic prostate cancer?”
Visit the article website.
Source: Akash Maniam/LinkedIn and JAMA Oncology/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 04:19
Feb 22, 2025, 03:56
Feb 22, 2025, 03:52
Feb 22, 2025, 03:21
Feb 22, 2025, 03:18